Loading...
XHKG
8225
Market cap20mUSD
May 29, Last price  
0.16HKD
1D
-2.42%
1Q
-10.56%
Jan 2017
-19.10%
IPO
-39.84%
Name

China Health Group Inc

Chart & Performance

D1W1MN
P/E
—
P/S
5.56
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.05%
Rev. gr., 5y
-15.99%
Revenues
26m
+23.47%
42,157,00057,052,00038,729,00039,186,00047,308,00037,687,00018,099,00028,688,00014,931,0005,956,00020,497,00020,241,00058,491,00059,606,00063,216,00083,063,00083,601,00013,090,00021,425,00026,454,000
Net income
-15m
L-74.97%
5,644,00015,563,0001,597,000-16,354,0006,276,000-56,928,000-153,796,0003,118,000-31,028,00044,117,000-3,353,0002,127,00030,454,00023,164,00027,792,00060,650,00036,325,000-15,843,000-58,014,000-14,519,000
CFO
0k
-100.00%
-734,000-1,836,000-22,623,000-30,653,0006,231,000-714,0006,716,000-6,617,000-1,779,00011,0003,390,000-6,893,00014,394,0002,858,000-485,00019,114,000-10,277,000-5,156,0001,121,0000
Dividend
Apr 07, 20040.005 HKD/sh

Profile

China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People's Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies. The company was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. China Health Group Inc. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
URL
http://www.chgi.net
IPO date
Jul 10, 2003
Employees
40
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
26,454
23.47%
21,425
63.67%
13,090
-84.34%
Cost of revenue
41,270
78,756
21,320
Unusual Expense (Income)
NOPBT
(14,816)
(57,331)
(8,230)
NOPBT Margin
Operating Taxes
46
17
Tax Rate
NOPAT
(14,862)
(57,331)
(8,247)
Net income
(14,519)
-74.97%
(58,014)
266.18%
(15,843)
-143.61%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
5,784
Net debt
(15,889)
(7,303)
(12,070)
Cash flow
Cash from operating activities
1,121
(5,156)
CAPEX
(6,004)
Cash from investing activities
(1,041)
(2,148)
Cash from financing activities
FCF
32,881
(29,089)
(3,297)
Balance
Cash
15,889
7,303
12,070
Long term investments
1
Excess cash
14,566
6,232
11,416
Stockholders' equity
69,717
34,941
103,603
Invested Capital
55,151
77,951
105,472
ROIC
ROCE
EV
Common stock shares outstanding
995,352
995,352
995,352
Price
0.20
44.20%
0.14
 
Market cap
198,075
44.20%
137,359
 
EV
181,550
129,420
EBITDA
(14,816)
(57,097)
(8,079)
EV/EBITDA
Interest
17
Interest/NOPBT